Wegovy 0.5 Mg Injection

Product Description

Wegovy 0.5mg FlexTouch is used along with a reduced-calorie diet and increased physical activity to help lower the risk of major heart-related events, such as heart attack, stroke, or cardiovascular death, in adults who have established heart disease and also have obesity or overweight. It is also prescribed for long-term weight management in adults and adolescents aged 12 years and older with obesity, and in adults with overweight who have a weight-related health condition. In addition, Wegovy 0.5mg FlexTouch is used to treat noncirrhotic nonalcoholic steatohepatitis (NASH) in adults who have moderate to advanced liver scarring.

Wegovy 0.5mg FlexTouch is administered as a once-weekly injection. It is generally injected under the skin in your abdomen, thigh, or upper arm. Get the injection on the same day each week, at a similar time, to maintain consistent levels in your body. Along with the treatment, maintain a healthy diet and exercise regularly for maximum benefits.

The most common side effects of Wegovy 0.5mg FlexTouch include nausea, vomiting, diarrhea, stomach pain, constipation, and headache. These symptoms often occur during the initial stage; however, they usually improve over time as your body adjusts to the medication. Eating smaller meals or avoiding heavy, fried foods may help ease symptoms like nausea or an upset stomach. If you experience severe or persistent side effects, consult your doctor for advice.

Before starting Wegovy 0.5mg FlexTouch, inform your doctor about any medical conditions you have, particularly a history of pancreatitis, eye problems caused by diabetes (diabetic retinopathy), thyroid cancer, or severe gastrointestinal problems. This medicine is not recommended for individuals with a personal or family history of medullary thyroid carcinoma or those with multiple endocrine neoplasia syndrome type 2 (MEN 2).

Additionally, discuss with your doctor if you are on medications for type 2 diabetes, such as insulin or sulfonylureas; combining Wegovy 0.5mg FlexTouch with these medications can increase the risk of low blood sugar levels (hypoglycemia). Your doctor may need to adjust your medicine dosage to ensure safe use.

Mechanism of Action

Wegovy contains Semaglutide, a synthetic GLP-1 receptor agonist. It helps regulate appetite by mimicking the action of a natural gut hormone, which increases feelings of fullness and reduces hunger. This mechanism supports individuals in achieving and maintaining significant weight loss when combined with a reduced-calorie diet and increased physical activity.


Usage Guidelines

This medication is recommended for adults who have a BMI of at least 30, or 27 with additional weight-related conditions such as hypertension or type 2 diabetes. Wegovy should be injected under the skin once a week, ideally at the same time each week, as directed by your physician. Dosage may be adjusted based on individual response and from physician guidance.


Packaging and Storage

Wegovy 0.5 mg is supplied as a pre-filled pen in a box, containing one dose per pen. The clear liquid must be stored in the refrigerator between 2C to 8C to maintain its efficacy. Always check the expiration date and keep the injection out of direct sunlight and away from children.


Safety and Prescription Information

Use of Wegovy requires a doctor's prescription and is not suitable for everyone. It is strictly contraindicated for individuals with a personal or family history of medullary thyroid carcinoma and those with a known allergy to Semaglutide. Consult your healthcare provider to determine if this medication is appropriate for you.